Literature DB >> 8350923

Positive selection of T lymphocytes on fibroblasts.

T Pawlowski1, J D Elliott, D Y Loh, U D Staerz.   

Abstract

Thymocytes are selected for expression of alpha beta T-cell antigen receptors (TCR) which recognize antigen in conjunction with self-major histocompatibility complex (MHC) molecules. In the thymus the restriction element is imprinted on radioresistant stromal elements and on cells of haematopoietic origin. In mice negative for beta 2-microglobulin that are devoid of mature cytotoxic T lymphocytes, we find that intrathymic injection of different fibroblasts causes the maturation of CD4-CD8+TCRhigh thymocytes with distinct patterns of TCR V beta distribution. Here we show that in TCR-transgenic mice, intrathymic injection of L cells expressing the selecting H-2Kb molecule (L-Kb cells) reconstitutes the maturation of thymocytes bearing the transgenic TCR, and that in normal B10.BR (H-2k) mice, H-2Kb molecules expressed on L-Kb cells lead to the development of T lymphocytes with recognition restricted to H-2Kb. A class I MHC restriction element can thus be selected by interaction with fibroblasts, that is, cells of other than epithelial or haematopoietic origin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350923     DOI: 10.1038/364642a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  20 in total

Review 1.  Review article: thymus organ cultures and T-cell receptor repertoire development.

Authors:  G Anderson; E J Jenkinson
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC.

Authors:  Marianne M Martinic; Maries F van den Broek; Thomas Rülicke; Christoph Huber; Bernhard Odermatt; Walter Reith; Edit Horvath; Raphael Zellweger; Katja Fink; Mike Recher; Bruno Eschli; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

3.  Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells.

Authors:  J Zerrahn; A Volkmann; M C Coles; W Held; F A Lemonnier; D H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells.

Authors:  R M Zinkernagel; A Althage
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 5.  Development of thymically derived natural regulatory T cells.

Authors:  Matthew L Bettini; Dario A A Vignali
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

6.  Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC.

Authors:  Marianne M Martinic; Thomas Rülicke; Alana Althage; Bernhard Odermatt; Matthias Höchli; Alain Lamarre; Tilman Dumrese; Daniel E Speiser; Diego Kyburz; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

7.  Impaired thymic selection and abnormal antigen-specific T cell responses in Foxn1(Δ/Δ) mutant mice.

Authors:  Shiyun Xiao; Nancy R Manley
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

Review 8.  The immunopathology of thymic GVHD.

Authors:  Werner Krenger; Georg A Holländer
Journal:  Semin Immunopathol       Date:  2008-10-31       Impact factor: 9.623

9.  Factors affecting success of thymus transplantation for complete DiGeorge anomaly.

Authors:  M L Markert; B H Devlin; I K Chinn; E A McCarthy; Y J Li
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

10.  Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells.

Authors:  Y Adachi; H Koseki; M Zijlstra; M Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.